Objective Cognitive and affective dysfunctions are important aspects for patients with multiple sclerosis (MS) and neuromyelitis optica (NMO). Methods We herein examined the cognitive and affective ability in MS (n=35) and NMO (n=10) patients using computerized touch panel-type screening tests. Results While MS patients and normal controls (NC1, n=40) did not significantly differ in their scores from the Hasegawa dementia scale-revised (HDS-R) or the frontal assessment battery, MS patients did score significantly lower on the mini-mental state examination (MMSE). In contrast, NMO patients did not differ from the normal control group 2 (NC2, n=15) in any of the three cognitive assessments. We also examined the affective ability and found that MS patients scored significantly higher on the apathy scale (AS) compared with the NC1 group, while NMO patients scored significantly higher on the geriatric depression scale (GDS) compared with the NC2 group. Although the GDS and AS scores did not correlate with any of the cognitive assessments among MS patients, the AS scores did correlate with the MMSE and HDS-R among NMO patients. Compared with normal controls, the times to complete the flipping cards and arranging pictures games were significantly longer for MS patients but not for NMO patients. Conclusion These results indicate differences between some features of cognitive and affective dysfunctions between MS and NMO patients. Computerized touch panel-type screening tests may be a more useful and sensitive tool for the cognitive assessment of MS patients than NMO patients.
Introduction
Multiple sclerosis (MS) and neuromyelitis optica (NMO) are chronic demyelinating and inflammatory diseases of the central nervous system. In MS patients, lesions are located throughout the central nervous system, including the optic nerve, cerebrum, cerebellum, brainstem, and spinal cord (1) . The pathology has complicated associations between T helper 17 cells (Th17), CD4+ and CD8+ T-cells (2) , and regulatory T cells (Treg) (3) . NMO is characterized by optic neuritis and myelitis (4, 5) . A specific protein, aquaporin 4 (AQP4), was recently identified at the blood-brain barrier in NMO patients and suggested as an autoimmune channelopathy in the central nervous system (6) .
In terms of cognitive function, 45-65% of MS patients show cognitive decline over the course of the disease (7) , especially in the areas of working memory, attention, verbal fluency, and speed of information processing (8) (9) (10) . Similarly, reports have shown impairments in attention, speed of information processing, and word generation in NMO patients (11) which changed after an acute relapse (12) . In addition to the cognitive decline, affective dysfunction is another important feature used to evaluate mental function in MS and NMO patients. Indeed, recent reports show that MS patients score higher that healthy people on apathy tests (13, 14) and NMO patients score higher than MS patients on depression scales (15) . We, and other groups, have previously reported the efficacy of a computerized touch panel-type screening test for the early detection of Alzheimer's disease (AD), ischemic stroke (IS), Parkinson disease (PD), and amyotrophic lateral sclerosis (ALS) (16) (17) (18) (19) (20) (21) . However, such a computerized touch panel-type test has never been given to MS and NMO patients. The aim of the present study, therefore, was to examine cognitive and affective abilities in MS and NMO patients as determined by the computerized touch panel-type screening tests.
Materials and Methods

Participants
Thirty-five MS patients (9 men, 26 women; age, 42.7± 12.7 years) and 10 NMO patients (3 men and 7 women; age, 53.8±10.9 years) who obtained medical care at the Okayama University Hospital between May 2010 to September 2013 were included in this study. Inclusion of MS and NMO patients was based on a confirmed diagnosis defined by the revised McDonald criteria (22) and Wingerchuk criteria (5), respectively. Although a number of patients had been diagnosed before the revised McDonald or Wingerchuk criteria were established, all patients met the revised criteria. Fifty-five age-and gender-matched individuals who lacked any history of neurological or psychiatric disorders were included as normal controls in this study. They were divided into two groups: the normal control group 1 (NC1) comprised 40 people (13 men and 27 women; age, 42.7±12.8 years) to be compared with the MS subjects; the normal control group 2 (NC2) comprised 15 people (3 men and 12 women; age, 54.6±8.5 years) to be compared with the NMO subjects. Clinical details for each group are shown in Table 1. Of 18 untreated MS patients at the time of examination, 6 patients had initiated interferon self-injection after the examination, and 12 patients did not initiate treatment due to depression, other severe complications, refusal of injection, or relapse after the examination.
Cognitive and affective assessments
Cognitive functions were assessed using the mini-mental state examination (MMSE) (23), Hasegawa dementia scalerevised (HDS-R) (24) , and frontal assessment battery (FAB) (25) . Affective functions, such as depression and apathy, were assessed using the 15-item geriatric depression scale (GDS) (26, 27) and the apathy scale (AS) (28) .
The MMSE evaluates seven aspects of cognition, such as orientation, registration, attention and calculation, recall, comprehension of spoken language (naming objects, spoken language ability, following commands), writing, and construction drawing (23) . The HDS-R evaluates orientation, immediate recall, serial subtraction, backward digit recitation, recall of 3 words, recall of 5 objects, and verbal fluency (generating names of vegetables) (24) . The FAB is a 6-item scale designed to evaluate frontal deficits, including conceptualization (similarities test), mental flexibility (lexical fluency), motor programming (Luria's fist-edge-palm test, conflicting instructions, and Go/No-Go tests), and environmental autonomy (prehension behavior) (25) . The GDS involves a screening questionnaire for depression and anxiety. Total scores range from 0 to 15, with higher scores indicating more symptoms of depression (26, 27) . AS scores range from 0 to 42, with higher scores indicating more severe apathy; a cutoff score of 14 points indicates "with apathy" (28) .
Touch panel-type screening test
A touch panel-type screening test for the early diagnosis of dementia (the Ryokansan , Ohtsu Computer Corp, Ohtsu, Japan) was administered to all subjects. The touch panel was large and the test did not include tasks, such as writing, that require fine manual dexterity. The screening test consisted of the following four games: beating devils, flipping cards, arranging pictures, and finding mistakes. We recorded the accuracy (percent correct) in the beating devils game and the time taken to complete the game for the other three games.
In the beating devils game (Fig. 1A) , the patients were instructed to distinguish between the emergence of heroes and devils, and we measured their accuracy in exterminating only the devils during a 30-second(s) period. In the flipping cards game (Fig. 1B) , we measured the time taken (seconds) to turn over all pairs of matching picture cards. In the arranging pictures game (Fig. 1C) , we measured the time taken (seconds) to arrange four scenes from a famous fairy tale in the correct order. In the finding mistakes game (Fig. 1D) , we measured the time taken (seconds) to find all three mistakes between the panels. Although the specific cognitive functions reflected by each task are unclear, in broad terms the flipping card game reflects recent memory, the arranging pictures game reflects processing ability and remote memory, the finding mistakes game reflects discrimination ability, and the beating devil game reflects judgment ability (16) .
Statistical analysis
Statistical analyses were performed using statistical software (SPSS 18.0.0, SPSS Inc., Chicago, USA). We performed unpaired t-tests to compare cognitive and affective assessments and touch panel-type screening tests between the MS and NMO groups and between each control group (NC1 or NC2). Spearman's rank correlation-coefficient tests and a simple regression analysis were conducted to examine correlations among the clinical features and each test separately in the MS and NMO groups. p values less than 0.05 were considered to be significant. (Fig. 2) . (Fig. 3,  top) .
Results
Cognitive and affective assessments
Compared with normal controls, NMO patients showed a tendency to take more time to complete the flipping cards game (NMO: 26.6±21.7 s; NC2: 12.1±5.0 s) and the arranging pictures game (NMO: 34.1±38.0 s; NC2: 12.3±8.4 s), but this difference was not significant (Fig. 3, lower-left) . NMO patients and normal controls did not differ in their times to complete the finding mistakes game (NMO: 29.2± 18.7 s; NC2: 30.4±23.8 s) or in their accuracy in the beating devils game (NMO: 86.1±29.3%; NC2: 97.7±2.7%) (Fig. 3 , lower-right). Tables 2 and 3 show the correlation coefficients among the clinical features, all cognitive assessments, and all affective assessments in MS and NMO patients, respectively. For MS patients, scores on the expanded disability status scale (EDSS) were significantly correlated with those on three of the four touch panel-type screening tests (Table 2) . For NMO patients, while EDSS scores did not correlate with scores from any of the touch panel-type screening tests, they did correlate with AS scores (Table 3 ). Furthermore, for MS patients, significant correlations were found between the MMSA and HDS-R scores and the flipping cards and finding mistakes game scores. HDS-R scores also significantly correlated with scores on the arranging pictures game (Table 2). Conversely, these correlations were not found in the NMO patients (Table 3) . Additionally, while GDS scores were significantly correlated with the number of relapses in MS patients (Table 2) , AS scores were correlated with scores from the MMSE, HDS-R, and the finding mistakes game in NMO patients. 
Correlation among clinical features, all cognitive assessments, and all affective assessments
Regression analysis
A regression analysis of the flipping cards and finding mistakes games with MMSE scores are shown in Figs. 3 and 4 for MS and NMO patients, respectively. As the cognitive function decreased, the time needed to finish the flipping cards game (R=-0.439, p<0.01) and the finding mistakes game (R=-0.574, p<0.01) rose significantly in MS patients (Fig. 4) . Although NMO patients showed a similar tendency (flipping cards game, R=-0.603; finding mistakes game, R=-0.379), there was no significant difference (Fig. 3) .
Discussion
The present study revealed that cognitive function as measured by the MMSE was slightly lower in MS patients, but not in NMO patients, when compared with the normal controls (Fig. 2, left) . Regarding affect, MS patients showed significantly higher levels of apathy compared with normal controls, while NMO patients showed significantly higher levels of depressive symptoms (Fig. 2, right) . Although MS patients did not show any correlations between affective and cognitive assessments (Table 2) , NMO patients showed a correlation between cognitive ability and the degree of apathy (Table 3 ). The time needed to complete the flipping cards and arranging pictures games was significantly longer in the MS patients (Fig. 3, 4) , but not in the NMO patients (Fig. 3, 5) .
Cognitive impairment is known to be a common complication in MS and NMO patients (29) with impairment levels being roughly similar between the two (11). However, in the present study, we showed that only MS patients had decreased cognitive ability, even though MS patients were younger than NMO patients (42.7±12.7 years vs. 53.8±10.9 years, respectively) ( Table 1) . A previous report that suggested similar features between cognitive function measures in MS and NMO patients (11) enrolled patients with similar ages (MS: 37.93±10.57 years, NMO: 36.86±12.42 years), disease duration (MS: 6.62±6.52 years, NMO: 8.62±4.35 years), and EDSS (MS: 2.2±1.68, NMO: 4.31±2.59) to our patients (Table 1) . Because the reduction tendency of cognitive function measures between MS and NMO patients in their report is similar to our report, significant differences may also be observed in NMO patients if more NMO patients are enrolled.
Although MS and NMO patients did not have similar affects, both differed from the controls (Fig. 1) , with MS patients showing higher levels of apathy and NMO patients showing higher levels of depressive symptoms. Similar to a previous report (30) , we found that affective and cognitive assessments were not correlated in MS patients (Table 2) . Also similar to a previous report (15) , our NMO patients showed more depressive symptoms than MS patients (Fig. 2) . A novel finding here is that the apathy level correlated with cognitive assessments in NMO patients (Table 3) . Table 2 We have previously reported on cognitive assessment data obtained via touch panel-type screening tests in patients with IS (16), PD (17) , and ALS (20) . Specific features of each disease correlated with cognitive dysfunction, such as white matter hyperintensities in IS patients (31) , longer disease duration (32) and higher disability (33) in PD patients, and severity of bulbar palsy in ALS patients (20) . Cognitive impairment in MS patients has been shown to correlate with the volume of white matter lesions and the number of cortical lesions (34) . Here, the total number of intracranial lesions, particularly periventricular lesions, correlated with the FAB scores in MS patients (Table 2) but not in NMO patients (Table 3) . Similarly, although cognitive impairment in MS patients was associated with disease duration and degree of disability (Table 2) , it was not associated with either factor in NMO patients (Table 3) .
Although the MMSE, HDS-R, and FAB are widely used measures of cognitive function, patients usually take more than 25 minutes to complete the entire battery of tests. As we previously reported, the touch panel-type screening test is very simple, takes much less time, and patients may even enjoy the tests (16, 17, 20) . MS patients had significantly lower scores on only one cognitive assessment scale (MMSE), but showed significant delays in two touch paneltype tests (flipping cards and arranging pictures) (Fig. 2, 3) . Moreover, the MMSE scores significantly correlated with the flipping cards game but not with the affective function measures (Table 2) . Thus, the touch panel-type screening tests may be useful and sensitive tools for detecting cognitive decline in MS patients as well as patients suffering from IS, PD, or ALS (16, 17, 20) .
In conclusion, although the diseases are generally similar, the present study showed differences between MS and NMO patients in cognitive and affective dysfunctions. Touch panel-type screening tests may be a more useful and sensitive tool for cognitive assessment in MS patients than in NMO patients (Fig. 2-5 ).
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